Last updated 2026-06-18
- Raised $3.3M funding round led by Entrée Capital, Nov 2024
- Raised funding round, Oct 2021
Total raised
$3.3M
Last: 2024-11
Stage
Seed
Founded
2021
Headcount
8
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals.
Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.
Funding history · 2 rounds · $3.3M total
2021-10
Undisclosed
Q&A
- What is caVos Biotherapeutics' primary focus?
- caVos Biotherapeutics is developing novel anti-cancer drugs by using a multi-level genomic algorithm to uncover the genetic basis of cancer resistance found in animals.
- When was caVos Biotherapeutics founded?
- caVos Biotherapeutics was founded in April 2021.
- How many employees does caVos Biotherapeutics currently have?
- caVos Biotherapeutics has 1-10 employees.
- What is the total amount of funding caVos Biotherapeutics has raised to date?
- caVos Biotherapeutics has raised a total of $3,300,000 USD.
- When was caVos Biotherapeutics' most recent funding round, and who were the lead investors?
- caVos Biotherapeutics' most recent funding round was in November 2024, with Entrée Capital as a lead investor.
- What is caVos Biotherapeutics' current funding stage?
- caVos Biotherapeutics is currently in the Seed funding stage.
- What sector does caVos Biotherapeutics primarily operate in?
- caVos Biotherapeutics primarily operates in the Health Tech & Life Sciences sector.
- What technologies does caVos Biotherapeutics utilize in its work?
- caVos Biotherapeutics utilizes Biologicals and Genes technologies.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
genomicscancer-researchdrug-discoverypharmaceuticalsdrug-developmentcancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/78737148 |
Identifiers & details
| Founded | 2021-4 |
|---|---|
| Employees (exact) | 8 |